Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Penumbra Stock Zoomed 4% Higher Today


News about one of 's (NYSE: PEN) development programs and an analyst's price target raise combined to boost the medical device company's stock on Monday. Its price rose by over 4%, giving the stock a clear victory over the S 500 index, which increased by 0.8%.

Penumbra announced that it has completed patient enrollment for a clinical trial to evaluate its Penumbra System with Thunderbolt Aspiration Tubing, a computer-assisted vacuum thrombectomy (CAVT) device. A thrombectomy is the medical removal of blood clots in the brain, a major risk factor for stroke.

The medical device specialist quoted its CEO, Adam Elsesser, as saying, "This critical milestone brings us another step closer to providing physicians with the latest technology for stroke management."

Continue reading


Source Fool.com

Penumbra Inc Stock

€281.60
-0.490%
The price for the Penumbra Inc stock decreased slightly today. Compared to yesterday there is a change of -€1.400 (-0.490%).

Like: 0
PEN
Share

Comments